Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Akihiko Ozaki and Anju Murayama.
Akihiko Ozaki
Connection Strength
0.348
Anju Murayama
  1. Coronavirus disease 2019 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies. Clin Microbiol Infect. 2020 Dec 11.
    View in: PubMed
    Score: 0.229
  2. Limited capacity of SARS-CoV-2 variants testing in Japan: A secondary analysis using publicly available data. Travel Med Infect Dis. 2021 Sep-Oct; 43:102145.
    View in: PubMed
    Score: 0.060
  3. Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir. Clin Pharmacol Ther. 2022 03; 111(3):545-547.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.